Breast tumours can be classified into four subtypes according to the presence or absence of hormone receptors (estrogen (ER) and progesterone receptors (PR)) and the overexpression of human epidermal growth factor receptor 2 (HER2) in combination with a set of clinical features. Here, ERBB2 is linked to breast neoplasm.